Sphenoorbital Meningioma Management.

Brain Meningioma Clinical Trial

Official title:

Spheno_orbital Meningioma Enplaque With Proptosis; Surgical Techniques and Outcomes

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04710485
• Other study ID #: Mng
• Status: Not yet recruiting
• Start date: January 30, 2021
• Est. completion date: January 1, 2023

Study information

• Verified date: January 2021
• Source: Assiut University
• Contact: Mostafa Mk Kashef, Assistant lecturer
• Phone: 01012962093
• Email: mostafakashef99[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Investigators will discuss the different surgical techniques for removal of spheno_orbital meningiomas with proptosis.investigators also will follow up the patient to know the outcome of removal of these tumours.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 24
• Est. completion date: January 1, 2023
• Est. primary completion date: December 20, 2022
• Gender: All
• Age group: 5 Years to 90 Years

Eligibility

Inclusion Criteria:

• all patients who have spheno_orbital meningioma with proptosis and candidate for surgery.

Exclusion Criteria:

• all patients have proptosis caused by other lesions than spheno_orbital meningioma.

Related Conditions & MeSH terms

• Brain Meningioma
• Meningioma

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical assessment for vision.	With visual acuity examination	For 6 months
Primary	Clinical assessment for proptosis	With proptosis index	For 6 months